300676.SZ SHZ
BGI Genomics Co., Ltd.
1W: +4.7%
1M: +17.9%
3M: +27.9%
YTD: -8.0%
1Y: -12.1%
3Y: -22.2%
5Y: -58.8%
¥45.86 ($6.84)
+1.70 (+3.85%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$12.5B
-7.9% ▼
5Y CAGR: +16.2%
Total Liabilities
$3.3B
-9.4% ▼
5Y CAGR: +16.7%
Shareholders Equity
$9.1B
-7.3% ▼
5Y CAGR: +16.2%
Cash & Investments
$4.3B
-21.4% ▼
5Y CAGR: +28.8%
Total Debt
$414M
+46.0% ▲
5Y CAGR: +48.9%
Net Debt
-$3.5B
+20.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5.4B | $6.6B | $5.2B | $4.7B | $3.9B |
| Short-Term Investments | $0 | $2.0B | $1.2B | $754M | $375M |
| Cash & ST Investments | $5.4B | $8.6B | $6.4B | $5.5B | $4.3B |
| Net Receivables | $1.6B | $1.2B | $2.2B | $1.5B | $1.8B |
| Inventory | $1.0B | $878M | $718M | $602M | $602M |
| Other Current Assets | $401M | $194M | $186M | $293M | $183M |
| Total Current Assets | $8.4B | $11.0B | $9.8B | $7.9B | $6.9B |
| Property, Plant & Equip. | $1.3B | $1.4B | $2.2B | $3.2B | $2.9B |
| Goodwill & Intangibles | $226M | $370M | $576M | $627M | $545M |
| Long-Term Investments | $865M | -$1.2B | $96M | $499M | $931M |
| Other Non-Current Assets | $237M | $2.4B | $1.5B | $1.1B | $1.1B |
| Total Non-Current Assets | $2.8B | $3.2B | $4.6B | $5.7B | $5.7B |
| Total Assets | $11.2B | $14.3B | $14.4B | $13.6B | $12.5B |
| — Liabilities — | |||||
| Accounts Payable | $873M | $805M | $1.0B | $865M | $78M |
| Short-Term Debt | $563M | $5M | $0 | $24M | $25M |
| Deferred Revenue | $2.2B | $2.4B | $929M | $0 | $0 |
| Other Current Liabilities | $160M | $1.3B | $3.1B | $1.5B | $1.8B |
| Total Current Liabilities | $3.8B | $3.4B | $3.9B | $3.3B | $2.8B |
| Long-Term Debt | $658M | $632M | $0 | $216M | $339M |
| Other Non-Current Liab. | $626M | $672M | $0 | $15M | $0 |
| Total Non-Current Liabilities | $1.4B | $1.4B | $208M | $312M | $429M |
| Total Liabilities | $5.2B | $4.8B | $4.2B | $3.6B | $3.3B |
| — Equity — | |||||
| Common Stock | $400M | $414M | $414M | $414M | $416M |
| Retained Earnings | $3.0B | $4.3B | $4.9B | $4.6B | $3.7B |
| Accumulated OCI | $199M | $341M | $478M | $0 | $0 |
| Total Stockholders Equity | $5.9B | $9.3B | $10.1B | $9.9B | $9.1B |
| Total Liabilities & Equity | $11.2B | $14.3B | $14.4B | $13.6B | $12.5B |
| — Key Metrics — | |||||
| Total Debt | $1.3B | $870M | $946M | $283M | $414M |
| Net Debt | -$4.1B | -$5.7B | -$4.2B | -$4.4B | -$3.5B |
| Total Investments | $865M | $898M | $1.3B | $1.3B | $1.3B |